25 related articles for article (PubMed ID: 16021618)
1. Buspirone, fexofenadine, and omeprazole: quantification of probe drugs and their metabolites in human plasma.
Gor P; Alnouti Y; Reed GA
J Pharm Biomed Anal; 2011 Jul; 55(5):1127-35. PubMed ID: 21546194
[TBL] [Abstract][Full Text] [Related]
2. Formulation of Dosage Forms with Proton Pump Inhibitors: State of the Art, Challenges and Future Perspectives.
Srebro J; Brniak W; Mendyk A
Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297478
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a high throughput UPLC-MS/MS method for simultaneous quantification of esomeprazole, rabeprazole and levosulpiride in human plasma.
Chunduri RHB; Dannana GS
J Pharm Anal; 2016 Jun; 6(3):190-198. PubMed ID: 29403981
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a UPLC Method by the QbD-Approach for the Estimation of Rabeprazole and Levosulpiride from Capsules.
Thummala VR; Seshadri RK; Tharlapu SS; Ivaturi MR; Nittala SR
Sci Pharm; 2014; 82(2):307-26. PubMed ID: 24959404
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Stability-Indicating RP-HPLC Method for the Determination of Process-Related Impurities and Degradation Products of Rabeprazole Sodium in Pharmaceutical Formulation.
Kumar N; Sangeetha D
Sci Pharm; 2013; 81(3):697-711. PubMed ID: 24106668
[TBL] [Abstract][Full Text] [Related]
6. Quantitative estimation of itopride hydrochloride and rabeprazole sodium from capsule formulation.
Pillai S; Singhvi I
Indian J Pharm Sci; 2008 Sep; 70(5):658-61. PubMed ID: 21394269
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous HPTLC Determination of Rabeprazole and Itopride Hydrochloride From Their Combined Dosage Form.
Suganthi A; John S; Ravi TK
Indian J Pharm Sci; 2008; 70(3):366-8. PubMed ID: 20046748
[TBL] [Abstract][Full Text] [Related]
8. Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole.
Yamagishi H; Koike T; Ohara S; Horii T; Kikuchi R; Kobayashi S; Abe Y; Iijima K; Imatani A; Suzuki K; Hishinuma T; Goto J; Shimosegawa T
World J Gastroenterol; 2008 Apr; 14(15):2406-10. PubMed ID: 18416470
[TBL] [Abstract][Full Text] [Related]
9. Early effects of Lansoprazole orally disintegrating tablets on intragastric pH in CYP2C19 extensive metabolizers.
Yamagishi H; Koike T; Ohara S; Horii T; Kikuchi R; Kobayashi S; Abe Y; Iijima K; Imatani A; Suzuki K; Hishinuma T; Goto J; Shimosegawa T
World J Gastroenterol; 2008 Apr; 14(13):2049-54. PubMed ID: 18395905
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous quantification of enalapril and enalaprilat in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study.
Lu S; Jiang K; Qin F; Lu X; Li F
J Pharm Biomed Anal; 2009 Jan; 49(1):163-7. PubMed ID: 19046843
[TBL] [Abstract][Full Text] [Related]
11. Incurred sample reanalysis (ISR): a decisive tool in bioanalytical research.
Yadav M; Shrivastav PS
Bioanalysis; 2011 May; 3(9):1007-24. PubMed ID: 21545349
[TBL] [Abstract][Full Text] [Related]
12. Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of rabeprazole in human plasma.
Huang J; Xu Y; Gao S; Rui L; Guo Q
Rapid Commun Mass Spectrom; 2005; 19(16):2321-4. PubMed ID: 16021618
[TBL] [Abstract][Full Text] [Related]
13. Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of lisinopril in human plasma.
Huang J; Xu Y; Liu F; Gao S; Guo Q
Rapid Commun Mass Spectrom; 2006; 20(2):248-52. PubMed ID: 16345121
[TBL] [Abstract][Full Text] [Related]
14. High-performance liquid chromatography method for the quantification of rabeprazole in human plasma using solid-phase extraction.
Ramakrishna NV; Vishwottam KN; Wishu S; Koteshwara M; Kumar SS
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):209-14. PubMed ID: 15664352
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of racecadotril metabolite in human plasma using a liquid chromatography/tandem mass spectrometry.
Xu Y; Huang J; Liu F; Gao S; Guo Q
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):101-7. PubMed ID: 17241825
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
